Peer-reviewed Publications Zhu, et al. 2020 Cell Stem Cell: Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-Tumor Activity READ MORE Zhu, et al. 2020 Blood: Pluripotent Stem Cell–Derived NK Cells with High-Affinity Noncleavable CD16a Mediate Improved Antitumor Activity READ MORE Zhu, et al. 2019 Method in Molecular Biology: An Improved Method to Produce Clinical-Scale Natural Killer Cells from Human Pluripotent Stem Cells READ MORE Li, et al. 2018 Cell Stem Cell: Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity READ MORE Yamamoto, et al. 2020 ASH: ADAM17-Deficient Pluripotent Stem Cell-Derived Natural Killer Cells Possess Improved Antibody-Dependent Cellular Cytotoxicity and Antitumor Activity READ MORE Goldenson, et al. 2020 Frontiers in Immunology: Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles READ MORE Knorr, et al. 2013 Stem Cells Translational Medicine: Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy READ MORE Reviews: Zhu, et al. 2018 Stem Cells: Concise Review: Human Pluripotent Stem Cells to Produce Cell-Based Cancer Immunotherapy READ MORE Wang, et al. 2019 Expert Opinion on Biological Therapy: The Rise of Human Stem Cell-Derived Natural Killer Cells for Cancer Immunotherapy READ MORE Bernareggi, et al. 2019 Experimental Hematology: Development of Innate Immune Cells from Human Pluripotent Stem Cells READ MORE
